Skip to main content
Funding Opportunities

Biology of Astrocytes in Parkinson’s Disease


The Michael J. Fox Foundation will award one-year to 18-month grants for studies that explore the role of astrocytes in Parkinson’s disease (PD) pathology and the potential for astrocyte-focused therapeutics. The goals of this funding program are to further understanding of astrocyte biology in Parkinson’s and to rationalize the pursuit of astrocyte-specific targets and/or pathways for the treatment of the disease.

What Fits:

Preference will be given to applications that focus on or include the following:

  • Role of astrocytes in initiating and/or propagating Parkinson’s disease pathology, including alpha-synuclein spread, dopaminergic neuron death, inflammation and senescence
  • Consequences of dysfunction and/or mutations of common PD targets, including alpha-synuclein, LRRK2, GBA, PRKN and PINK1
  • Manipulation of astrocyte activity and/or astrocyte-specific pathways to assess the potential of targeted astrocyte therapies on disease biology and/or symptoms
  • Parkinson’s disease models with high construct validity to human PD, including patient-derived material (such as iPSCs or cerebral organoids) and/or well characterized animal models and primary cells; Examination of human brain samples to answer specific hypotheses is also acceptable
  • Targets, pathways and mechanisms with reasonable links to PD

Informational Webinar

Watch a previously recorded webinar on our Foundation's funding strategy and opportunities, and the application and review processes

Watch Now

Application Process

1.  Download RFA and application template
2.  Log in or create account in the grant application portal
3.  Submit your completed application.

Contact with questions

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.